The excipient used in the oral formulation fails to adequately enhance the oral absorption of other peptides with structures similar to semaglutide 5
Patients with Prediabetes Prediabetes (HbA1c 5.7-6.4%) isnt an FDA-approved indication for Ozempic, but some providers prescribe it off-label to prevent progression to type 2 diabetes, especially in patients with additional risk factors
(1) Receptor Grade IGF-1 LR3 peptide, a polypeptide amino acid also known as Long arginine 3 IGF-1, or LR3-IGF-1, has been suggested to exhibit potential action similar to Insulin-like Growth factor-1, or IGF-1
Clinical studies demonstrate that GLP-1 agonists lower HbA1c by 0.81.8% in diabetic patients and produce weight loss of 515% in weight management applications
I find it interesting how few continue beyond 1+ year, and wonder what sort of yo-yo experience that could mean in the future years of benefit programs
In type 2 diabetes, either the body stops producing enough insulin or there is resistance to the action of insulin